Based on the expression profiles and outcome data in the GEPIA database, we found that ACADSB and MYCN are the favorable prognostic marker of ccRCC, while CDCA3, CHAC1, and TFAP2A are the unfavorable prognostic marker of ccRCC (Figure S2). Here, CHAC1 is linked to nonpapillary renal cell carcinoma.